Interaction of Rifampicin with Antihypertensive Medications in Chronic Kidney Disease Patients: Clinical Implications

Interaction of Rifampicin with Antihypertensive Medications in Chronic Kidney Disease Patients: Clinical Implications

Saved in:

Bibliographic Details
Main Authors:	Ramnik K. Duggal, Ganesh P. Agrawal
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2019-07-01
Series:	Indian Journal of Medical Specialities
Online Access:	https://journals.lww.com/10.4103/INJMS.INJMS_52_19
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Implications of Cognitive Impairment on Antihypertensive Medication Use in HIV
by: Azin Tavasoli, et al.
Published: (2025-03-01)

Effect of rifampicin on the kidney of albino rats
by: DE Peters, et al.
Published: (2013-07-01)

Interaction of the Antibiotic Rifampicin with Lipid Membranes
by: Rui M. S. Santos, et al.
Published: (2025-02-01)

SELECTION OF THE OPTIMAL ANTIHYPERTENSION TREATMENT IN PATIENTS WITH CHRONIC HEART FAILURE WITH THE SIGNS OF CHRONIC KIDNEY DISEASE
by: N. Yu Borovkova, et al.
Published: (2016-12-01)

Combined antihypertensive medications
by: L. L. Kirichenko, et al.
Published: (2007-12-01)

Drug interactions of antihypertensive agents
by: L.H. Opie
Published: (2012-04-01)

Combined antihypertensive therapy in patients with chronic obstructive pulmonary disease
by: M. V. Matsievich, et al.
Published: (2008-08-01)

Antihypertensive Effects of a Sodium Thiosulfate-Loaded Nanoparticle in a Juvenile Chronic Kidney Disease Rat Model
by: You-Lin Tain, et al.
Published: (2024-12-01)

Clinical use of a combined-action antihypertensive medication urapidil
by: N. I. Gaponova, et al.
Published: (2010-02-01)

Diabetes, Chronic Kidney Disease, and Vascular Ulcers: Prevention Strategies and Clinical Implications
by: Stefano Mancin, et al.
Published: (2025-02-01)

MicroRNAs and vascular damage in chronic kidney disease: advances and clinical implications
by: Regiane Stafim da Cunha, et al.
Published: (2025-05-01)

Parathyroid Hormone Measurement in Chronic Kidney Disease: From Basics to Clinical Implications
by: Kittrawee Kritmetapak, et al.
Published: (2019-01-01)

Drug-Gene Interactions of Antihypertensive Medications and Risk of Incident Cardiovascular Disease: A Pharmacogenomics Study from the CHARGE Consortium.
by: Joshua C Bis, et al.
Published: (2015-01-01)

The level of proteinuria and the state of endothelial function in patients with chronic kidney disease combined with subclinical hypothyroidism under the influence of combined antihypertensive therapy.
by: O. V. Kuryata, et al.
Published: (2018-05-01)

Histological effect of rifampicin drug in the kidney and liver of tissue of albino mice Mus Musclus
by: Muna Salah Rashid, et al.
Published: (2021-12-01)

CHOICE OF ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH ARTERIAL HYPERTENSION AND CHRONIC LIVER DISEASES
by: M. N. Mamedov, et al.
Published: (2016-01-01)

Association between antihypertensive medication use and kidney cancer risk: a meta-analysis accounting for hypertension
by: Minji Jung, et al.
Published: (2025-06-01)

Interaction between chronic kidney disease and intestinal microbiome
by: WANG Yi-hao, et al.
Published: (2019-01-01)

Circadian Rhythm of Blood Pressure: Implications for Antihypertensive Management
by: Barun Kumar, et al.
Published: (2021-04-01)

Economic and Health Implications of Risk Factors in Chronic Kidney Disease
by: Greeshma Gireesh
Published: (2025-02-01)

Combined effects of antihypertensive medications: computer prognosis
by: O. A. Gomaskov, et al.
Published: (2008-10-01)

Real-World Evaluation of the Interaction Between Rifampicin and Warfarin: A Retrospective Observational Study
by: Lina Naseralallah, et al.
Published: (2025-01-01)

PDIA3 rs2788, a risk factor for metabolic syndrome, interacted negatively with antihypertensive medications
by: Man Zheng, et al.
Published: (2025-08-01)

Characteristics of and treatment outcomes in rifampicin-intolerant patients
by: R. Mangat, et al.
Published: (2024-04-01)

Postdiagnostic use of antihypertensive medications and survival in colorectal, lung, corpus uteri, melanoma and kidney cancer patients with hypertension
by: Rūta Everatt, et al.
Published: (2025-01-01)

ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE: ADVANTAGES OF CALCIUM ANTAGONISTS
by: T. V. Adasheva, et al.
Published: (2016-01-01)

Impact of rpoB gene mutations and Rifampicin-resistance levels on treatment outcomes in Rifampicin-resistant tuberculosis
by: Maria Jose Vadakunnel, et al.
Published: (2025-02-01)

Effectiveness of Mobile Apps in Improving Medication Adherence Among Chronic Kidney Disease Patients: Systematic Review
by: Ganesh Sritheran Paneerselvam, et al.
Published: (2025-04-01)

Biological Cost of Helicobacter pylori Rifampicin Resistance
by: K. T. Momynaliev, et al.
Published: (2020-05-01)

Gut microbiome remodeling in chronic kidney disease: implications of kidney replacement therapies and therapeutic interventions
by: Qianwei Wang, et al.
Published: (2025-07-01)

The influence of gut microbiota on the gut-brain-kidney axis and its implications for chronic kidney disease
by: Jue Zhu, et al.
Published: (2025-07-01)

Metabolic effects of antihypertensive medications: prognostic role in the development of cardiovascular disease and diabetes mellitus
by: M. V. Stroeva, et al.
Published: (2010-04-01)

Sodium-glucose cotransporter 2 inhibitors in chronic kidney disease: A review of current evidence and clinical implications
by: Abdulrahman Saad Alfaiz
Published: (2025-06-01)

Periodontal Disease in Chronic Kidney Disease Patients: Implications for Systemic Health and Dental Management
by: Tayyaba Rafiq, et al.
Published: (2025-04-01)

Higher Dose of Rifampicin for Tuberculosis: Practical Issues
by: Ravindran Chetambath
Published: (2025-04-01)

ANTIHYPERTENSIVE THERAPY IN PATIENTS WITH METABOLIC SYNDROME: CHOOSING THE BASIS MEDICATION
by: M. V. Lebedeva
Published: (2011-04-01)

Antihypertensive therapy and medication adherence in patients with uncontrolled arterial hypertension
by: T. D. Solntseva, et al.
Published: (2023-11-01)

IMPACT OF MODERN ANTIHYPERTENSION MEDICATIONS ON THE CENTRAL PRESSURE AND ARTERIAL RIGIDITY
by: L. I. Gusakovskaya, et al.
Published: (2015-10-01)

Development and Validation of Predictive Models for Non-Adherence to Antihypertensive Medication
by: Cristian Daniel Marineci, et al.
Published: (2025-07-01)

THE ROLE OF ANTIHYPERTENSIVE MEDICATIONS IN THE MANAGEMENT OF CEREBROVASCULAR COMPLICATIONS IN ARTERIAL HYPERTENSION
by: N. U. Makhkamova, et al.
Published: (2009-12-01)